Effect of hepatitis on surgical treatment and prognosis of colorectal liver metastasis.
- Author:
Ming LIU
1
;
Kun WANG
;
Yi SUN
;
Quan BAO
;
Hongwei WANG
;
Kemin JIN
;
Baocai XING
Author Information
- Publication Type:Journal Article
- MeSH: Colorectal Neoplasms; Drainage; Hepatectomy; Hepatitis; Humans; Liver Neoplasms; Operative Time; Prognosis; Retrospective Studies
- From: Chinese Journal of Gastrointestinal Surgery 2015;18(7):680-683
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the effect of hepatitis on surgical treatment and prognosis of colorectal liver metastasis(CRLM).
METHODSA retrospective study of medical records of all the patients undergoing operation with colorectal liver metastasis in Peking University Hepatobiliary pancreatic Surgery Ward I from November 2007 to January 2013 was conducted. A total of 175 patients were eligible and divided into two groups: with hepatitis (n=16) or without hepatitis (n=159).
RESULTSPreoperative liver function was similar in these two groups. There were no significant differences in preoperative serum albumin, total bilirubin and prothrombin time between two groups (all P>0.05), except for lower blood platelet in hepatitis group after operation. Major hepatectomy was performed in 37.5% (6/16) and 22.0% (15/159) of two groups respectively (P>0.05). There were also no significant differences in operation time, blood loss, surgical complications and drainage volume (all P>0.05). The median overall survival time was 46 months in hepatitis group and 33 months in non-hepatitis group, and the median disease free time was 8 months in hepatitis group and 10 months in non-hepatitis group (all P>0.05).
CONCLUSIONCRLM patients concomitant with hepatitis have adequate liver reserve function for major hepatic resection and have similar prognosis of patients without hepatitis.